August 23, 2017 5:45 PM ET

Biotechnology

Company Overview of VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc.

Key Executives for VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc.

NameBoard RelationshipsTitleAge
Jeff R. Baxter FCMA28 RelationshipsChief Executive Officer, President and Director56
Francisco Diaz-Mitoma M.D., Ph.D.10 RelationshipsFounder62

VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Steven S. Gillis M.D., Ph.D. 173 RelationshipsArch Venture Partners, L.P.64
Jeff R. Baxter FCMA 28 RelationshipsVBI Vaccines Inc.56
Scott Requadt J.D., MBA 21 RelationshipsPhoenix Strategy Investments, LLC49
Alan P. Timmins 17 RelationshipsYamhill Valley Vineyards Inc57
Stanley A. Plotkin M.D. 80 RelationshipsMymetics Corporation84
View All Board Members

VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Alan P. Timmins17 Relationships3 Executives
Compensation Committee J.D., MBAScott Requadt21 Relationships2 Executives
Nominating Committee M.D., Ph.D.Steven S. Gillis173 Relationships3 Executives
Corporate Governance Committee M.D., Ph.D.Steven S. Gillis173 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$400.0K
400.0K
390.3K
Bonus$180.0K
180.0K
239.6K
Total Short Term Compensation
Not meaningful
Total Value of Options$580.0K
580.0K
18.7M
Compensation as of Fiscal Year 2015
VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PCI Biotech Appoints Hans Olivecrona as Chief Medical Officer
August 23, 2017 6:00 AM ET
CTI BioPharma Corp. Announces Resignation of Matthew Plunkett as Executive Vice President, Chief Business Officer
August 22, 2017 9:22 PM ET
TARA Biosystems, Inc. Appoints Michael P. Graziano as Chief Scientific Officer
August 22, 2017 2:00 PM ET
Celgene Corporation Announces Executive Changes
August 22, 2017 1:23 PM ET
Aldevron Names Dr. Thomas Lynch as Vice President of Sales and Client Development
August 22, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VBI Vaccines Inc. Prior to merger with SciVac Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.